Table 1.
General characteristics of the study population at baseline (n = 108).
| Age | 72.7 ± 5.9 |
| Gender (males/females) | 58/50 |
| BMI (kg/m2) | 27.5 ± 4.1 |
| Total cholesterol (mg/L) | 196.9 ± 46.6 |
| HDL-C (mg/dL) | 47.9 ± 12.5 |
| LDL-C (mg/dL) | 118.3 ± 44.1 |
| Triglyceride (mg/dL) | 156.0 ± 69.2 |
| SBP (mmHg) | 139.2 ± 14.7 |
| DBP (mmHg) | 78.5 ± 7.6 |
| GSM | 31.5 ± 13.7 |
| NASCET (%) | 44.4 ± 20.9 |
| Hypertension, n (%) | 88 (81.5%) |
| Hypercholesterolemia, n (%) | 79 (73.2%) |
| Diabetes mellitus, n (%) | 22 (20.4%) |
| Smoking, n (%) | 16 (14.8%) |
| Creatinine (mg/dL) | 1.0 ± 0.2 |
| eGFR (mL/min/1.73 m2) | 71.1 ± 16.7 |
| SUA (mg/dL) | 6.1 ± 1.8 |
| SUA/SCr ratio | 6.2 ± 2.1 |
BMI: body mass index; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; SBP: systolic blood pressure; DBP: diastolic blood pressure; GSM: grayscale median; NASCET: North American Symptomatic Carotid Endarterectomy Trial; eGFR: estimated glomerular filtration rate; SUA: serum uric acid; SCr: serum creatinine.